New study uncovers metabolic vulnerability in high-risk myelodysplastic syndromes
Researchers at the University of Colorado Anschutz Cancer Center have identified a previously unknown metabolic weakness in the stem cells that drive high-risk myelodysplastic syndromes (MDS), a discovery that could…